170 related articles for article (PubMed ID: 18722917)
1. Clinical pharmacokinetics of isolated pelvic perfusion.
Belliveau JF; Wanebo HJ
Surg Oncol Clin N Am; 2008 Oct; 17(4):773-84, viii. PubMed ID: 18722917
[TBL] [Abstract][Full Text] [Related]
2. Pelvic perfusion for advanced colorectal cancers.
Begossi G; Belliveau JF; Wanebo HJ
Surg Oncol Clin N Am; 2008 Oct; 17(4):825-42, ix-x. PubMed ID: 18722921
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma.
Maruo T; Motoyama S; Hamana S; Yoshida S; Ohara N; Yamasaki M; Ku Y
Surg Oncol Clin N Am; 2008 Oct; 17(4):843-56, x. PubMed ID: 18722922
[TBL] [Abstract][Full Text] [Related]
4. Pressure-suit combined with pelvic stop-flow: a feasibility study in a bovine model.
Bonvalot S; Bonnay M; Drouard-Troalen L; Cavalcanti A; Le Péchoux C; Le Cesne A; Blay JY; Laborde F
Eur J Surg Oncol; 2007 Feb; 33(1):114-8. PubMed ID: 17088039
[TBL] [Abstract][Full Text] [Related]
5. Abdominal and pelvic stop-flow chemotherapy. Effect of chemotherapeutic agents and tissue ischemia on rectoanal pressures.
Chrysos E; Athanasakis E; Vrekousis T; Almarashdah S; Fiorentini G; Xynos E; Zoras O
J Exp Clin Cancer Res; 2006 Sep; 25(3):303-8. PubMed ID: 17167968
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion.
Wanebo HJ; Belliveau JF
Cancer Chemother Pharmacol; 1999; 43(5):427-34. PubMed ID: 10100600
[TBL] [Abstract][Full Text] [Related]
7. Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models.
Beasley GM; Kahn L; Tyler DS
Surg Oncol Clin N Am; 2008 Oct; 17(4):731-58, vii-viii. PubMed ID: 18722915
[TBL] [Abstract][Full Text] [Related]
8. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.
van Ijken MG; van Etten B; Brunstein F; ten Hagen TL; Guetens G; de Wilt JH; de Bruijn EA; Eggermont AM
Eur J Surg Oncol; 2005 Oct; 31(8):807-16. PubMed ID: 15951150
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic antiblastic stop-flow perfusion: clinical outcome and pharmacokinetic findings.
Miotto D; Miotto D; Bertolo S; Minante M; Darisi T; Mocellin S; Casara D; Ori C; Foletto M; Rossi CR; Lise M; Nitti D
J Chemother; 2004 Nov; 16 Suppl 5():44-7. PubMed ID: 15675477
[TBL] [Abstract][Full Text] [Related]
10. Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug.
Belliveau JF; Arevalo E; Griffin H; Wanebo HJ
Cancer Chemother Pharmacol; 2005 Apr; 55(4):318-322. PubMed ID: 15654643
[TBL] [Abstract][Full Text] [Related]
11. Palliation for pelvic carcinoma. A study of isolated pelvic perfusion with chemotherapeutic agents.
Swaney RN; Pace WG
Ohio State Med J; 1966 Aug; 62(8):795-7. PubMed ID: 5946211
[No Abstract] [Full Text] [Related]
12. Regional chemotherapy for carcinoma of the lung.
Müller H; Guadagni S
Surg Oncol Clin N Am; 2008 Oct; 17(4):895-917, xi. PubMed ID: 18722925
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 5-fluorouracil during hyperthermic pelvic isolation-perfusion.
Wile AG; Stemmer EA; Andrews PA; Murphy MP; Abramson IS; Howell SB
J Clin Oncol; 1985 Jun; 3(6):849-52. PubMed ID: 4009218
[TBL] [Abstract][Full Text] [Related]
14. Laboratory models of regional chemotherapy.
Ten Hagen TL; Eggermont AM
Int J Hyperthermia; 2008 May; 24(3):291-9. PubMed ID: 18393006
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma.
Kam PC; Thompson JF
Surg Oncol Clin N Am; 2008 Oct; 17(4):795-804, ix. PubMed ID: 18722919
[TBL] [Abstract][Full Text] [Related]
16. Isolated lung perfusion and related techniques for the treatment of pulmonary metastases.
Van Schil PE; Hendriks JM; van Putte BP; Stockman BA; Lauwers PR; Ten Broecke PW; Grootenboers MJ; Schramel FM
Eur J Cardiothorac Surg; 2008 Mar; 33(3):487-96. PubMed ID: 18226538
[TBL] [Abstract][Full Text] [Related]
17. [The locoregional chemotherapeutic treatment of neoplasms].
Lerza R; Mencoboni M
Recenti Prog Med; 1991 Feb; 82(2):115-20. PubMed ID: 2034866
[TBL] [Abstract][Full Text] [Related]
18. Isolated hepatic perfusion for the treatment of liver tumors: sunset or sunrise?
Verhoef C; de Wilt JH; ten Hagen TL; Eggermont AM
Surg Oncol Clin N Am; 2008 Oct; 17(4):877-94, xi. PubMed ID: 18722924
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics & drug resistance of melphalan in regional chemotherapy: ILP versus ILI.
Padussis JC; Steerman SN; Tyler DS; Mosca PJ
Int J Hyperthermia; 2008 May; 24(3):239-49. PubMed ID: 18393002
[TBL] [Abstract][Full Text] [Related]
20. The role of hypoxic stop-flow perfusion and high dose chemotherapy in the treatment of regionally advanced colorectal cancer.
Di Giorgio A; Franchi F; Di Seri M; Lacava V; Caroli S; Russo GE; Borzomati V; Al Mansour M
J Chemother; 1997 Dec; 9(6):436-41. PubMed ID: 9491845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
